Evolving Treatment Options for Metastatic Renal Cell Carcinoma (mRCC)
Approximately a third of patients diagnosed with kidney cancer in the United States present with advanced disease and those who present with distant metastases historically had dismal 5-year relative survival. However, over the last several years, advancements have led to improved life expectancy an...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2023-04-01
|
| Colección: | Uro |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2673-4397/3/2/14 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|